Gastric Cancer
Copyright ©The Author(s) 2002.
World J Gastroenterol. Dec 15, 2002; 8(6): 982-986
Published online Dec 15, 2002. doi: 10.3748/wjg.v8.i6.982
Figure 3
Figure 3 The expression of FADD protein in SGC-7901 cells fol-lowing treatment of VES for 24 h. Lane1: Molecular weight marker; Lane2: VES at 20 mg·L-1; Lane3: VES at 10 mg·L-1; Lane4: VES at 5 mg·L-1; Lane5: vitamin E; Lane6: succinate; Lane7: UT control.